cough and cold medicine from the shelves other companies with similar productshave done the same.McNeil Consumer Healthcare published a press release informing customers of theproducts that were recalled and what is happening with the company right now. The press release states that the products are recognized as safe and effectivewhen used as directed. It also states that if a parent has any questions about theirchildren’s health that they are to contact their pediatrician. (press release) The Houston Chronicle, the Wall Street Journal, MSNBC.com, and the USA Today, allpublished the same information about the voluntary recall that Tylenol and othercompanies participated in October. Each of these articles stated that the FDA wasgoing to investigate the effectiveness of infant cough and cold medicine that iscurrently on the market. It is also stated that there is a lack of studies that supportthe use of infant cough and cold medicine. Each article states that the best methodfor helping a child through a sickness is a humidifier, keeping them hydrated, andlots of love. If the sicknesslasts more than a couple of days then the parent is tocontact their pediatrician. Each article also states that parents are not to give theirinfants medicine made for adults or children, because the infant will be at a hugerisk of an overdose which is the reason the medicine that is made for infants waspulled from the shelf in the first place.
I am playing the role of Ashley McEvoy, President McNeil Consumer Healthcare, I amunder pressure to explain and justify the voluntary removal of infant cold medicinefrom shelves. The FDA is going to hold a hearing in October about the effectivenessof cold medicine for children younger than 2 years old. 123 Children have died fromingredients in cold medicine since 1969, most of them were under the age of 2.In a recent press release (October 11, 2007), Tylenolannounced the voluntaryremoval of all infant cough and cold products because of the upcoming hearing bythe FDA. Tylenol has stated that when the products are used as directed they are“generally safe and effective,” but that there is a small chance of overdose mostlyin children 2 and under.I am holding a press conference on October 11, 2007 for the general public in orderto dispel any fears about infant cough and cold medicine.
To explain the reason behind removing the product from theshelves and to restore the public’s trust in Tylenol products.
Reduce offensiveness (bolstering and compensation), andcorrective action.